842 results on '"Chen, Nai-Hong"'
Search Results
2. Corrigendum to 'Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis' [Biomed. Pharmacother. 92 (2017) 962–971]
3. Author Correction: Ginsenoside Rg1 protects against ischemic/reperfusion-induced neuronal injury through miR-144/Nrf2/ARE pathway
4. A novel small-molecular CCR5 antagonist promotes neural repair after stroke
5. Inflammation and Connexin 43 profiles in the prefrontal cortex are relevant to stress susceptibility and resilience in mice
6. A small molecule 20C from Gastrodia elata inhibits α-synuclein aggregation and prevents progression of Parkinson’s disease
7. Improvement of astrocytic gap junction involves the anti-depressive effect of celecoxib through inhibition of NF-κB
8. Distribution of α-Synuclein Aggregation in the Peripheral Tissues
9. Correction to: Exogenous Adenosine Antagonizes Excitatory Amino Acid Toxicity in Primary Astrocytes
10. Correction: CKLF1 Aggravates Focal Cerebral Ischemia Injury at Early Stage Partly by Modulating Microglia/Macrophage Toward M1 Polarization Through CCR4
11. Time-dependent dual effect of microglia in ischemic stroke
12. Mongolian medicine Wenguanmu ointment treats eczema by inhibiting the CKLF-1/NF-κB pathway
13. Corrigendum to “Effects of chronic mild stress on behavioral and neurobiological parameters—Role of glucocorticoid” [Horm. Behav. 2016 Feb: 78: 150–9. doi:10.1016/j.yhbeh.2015.11.006. Epub 2015 Nov 22]
14. The Role of AMPARs Composition and Trafficking in Synaptic Plasticity and Diseases
15. Connexin 43: insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy
16. CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurr1 signal pathways
17. Characteristics and pathogenesis of chemokines in the post-stroke stage
18. AD-16 Protects Against Hypoxic-Ischemic Brain Injury by Inhibiting Neuroinflammation
19. Mitophagy, a Form of Selective Autophagy, Plays an Essential Role in Mitochondrial Dynamics of Parkinson’s Disease
20. Ginsenoside Rg1 Plays a Neuroprotective Role in Regulating the Iron-Regulated Proteins and Against Lipid Peroxidation in Oligodendrocytes
21. Corrigendum to “IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization” [Int. Immunopharmacol. 70 (2019) 69–79]
22. Corrigendum to “RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3ß and JNK signaling pathways in dopaminergic neuron-like cells” [Brain Res. Bull. 146 (2019) 228–236]
23. Neuronal chemokine-like-factor 1 (CKLF1) up-regulation promotes M1 polarization of microglia in rat brain after stroke
24. Pyk2 inhibition attenuates hypoxic-ischemic brain injury in neonatal mice
25. Rg1 exerts protective effect in CPZ-induced demyelination mouse model via inhibiting CXCL10-mediated glial response
26. The versatile role of TREM2 in regulating of microglia fate in the ischemic stroke
27. The neuroinflammatory role of glucocerebrosidase in Parkinson's disease
28. Regulatory T cells in ischemic stroke
29. Parkin, an E3 Ubiquitin Ligase, Plays an Essential Role in Mitochondrial Quality Control in Parkinson’s Disease
30. Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington’s disease via suppressing MAPKs and NF-κB pathways in the striatum
31. Korean red ginseng alleviate depressive disorder by improving astrocyte gap junction function
32. Novel antidepressant mechanism of ginsenoside Rg1: Regulating biosynthesis and degradation of connexin43
33. Low corticosterone levels attenuate late life depression and enhance glutamatergic neurotransmission in female rats
34. Exogenous Adenosine Antagonizes Excitatory Amino Acid Toxicity in Primary Astrocytes
35. HS-GC-IMS-Based metabonomics study of Baihe Jizihuang Tang in a rat model of chronic unpredictable mild stress
36. Endoplasmic reticulum stress, an important factor in the development of Parkinson’s disease
37. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
38. The function of astrocytes and their role in neurological diseases
39. Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
40. Donepezil attenuates vascular dementia in rats through increasing BDNF induced by reducing HDAC6 nuclear translocation
41. Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-κB signaling and modulation of M1/M2 polarization
42. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease
43. Nevadensin
44. Quinine
45. Indirubin
46. Sinomenine
47. Gossypol
48. Ginsenoside Rg3
49. Cepharanthine
50. Berbamine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.